Lewes, Delaware, May 02, 2025 ( GLOBE NEWSWIRE ) -- The Global Healthcare Logistics Market Size is projected to grow at a CAGR of 9.68% from 2024 to 2031, according to a new report published by Verified Market Research®.

Alamos Gold AGI has outperformed the market over the past 5 years by 9.66% on an annualized basis producing an average annual return of 24.18%. Currently, Alamos Gold has a market capitalization of $10.57 billion.

U.S. stocks traded higher this morning, with the S&P 500 gaining over 1% on Friday. Following the market opening Friday, the Dow traded up 0.91% to 41,121.95 while the NASDAQ climbed 1.11% to 17,906.97. The S&P 500 also rose, gaining, 1.06% to 5,663.28. Industrials shares rose by 1.6% on Friday.

Key takeaways:XRP's strongest spot premium phase suggests real buying demand, not just speculative futures trading. The number of XRP addresses holding ≥10,000 tokens has steadily climbed, even during recent price pullbacks.

Constellation Brands STZ has outperformed the market over the past 20 years by 1.88% on an annualized basis producing an average annual return of 10.09%. Currently, Constellation Brands has a market capitalization of $33.31 billion.

Chevron shares fell premarket after revenue missed estimates; adjusted EPS was in line, but down Y/Y. Production was flat Y/Y, but the company returned $6.9B to shareholders via dividends and buybacks.

XIAMEN, China, May 02, 2025 ( GLOBE NEWSWIRE ) -- Blue Hat Interactive Entertainment Technology ( "Blue Hat" or the "Company" ) ( NASDAQ: BHAT ) today released its audited financial results for the fiscal year ended December 31, 2024. Under the strategic guidance of management, the company ...

It's hard to find a biotech company that has performed better than Summit Therapeutics ( NASDAQ: SMMT ) in the past year. The stock is up by a whopping 512%, and it's no secret why.Summit, a specialist in oncology, has made excellent clinical progress with its leading candidate, ivonescimab.

Longeveron (LGVN) will report Q1 2025 financial results and provide a business update on Thursday, May 8, 2025 after the U.S. financial markets close.

Alvotech ( NASDAQ: ALVO ) , a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first quarter ended March 31, 2025, after U.S. markets close on Wednesday, May 7, ...